<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8163D851-26A0-4CAD-9A5E-261DB92BD7AE"><gtr:id>8163D851-26A0-4CAD-9A5E-261DB92BD7AE</gtr:id><gtr:name>Gelexir Healthcare Limited</gtr:name><gtr:address><gtr:line1>THE OBSERVATORY , CHAPEL WALKS</gtr:line1><gtr:city>MANCHESTER</gtr:city><gtr:postCode>M2 1HL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8163D851-26A0-4CAD-9A5E-261DB92BD7AE" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>8163D851-26A0-4CAD-9A5E-261DB92BD7AE</gtr:id><gtr:name>Gelexir Healthcare Limited</gtr:name><gtr:address><gtr:line1>THE OBSERVATORY , CHAPEL WALKS</gtr:line1><gtr:city>MANCHESTER</gtr:city><gtr:postCode>M2 1HL</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>250000.0</gtr:offerGrant><gtr:projectCost>835645.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CF0C1687-CAA0-46CD-860A-8A2B5D3F2A56"><gtr:id>CF0C1687-CAA0-46CD-860A-8A2B5D3F2A56</gtr:id><gtr:firstName>Philippe</gtr:firstName><gtr:surname>Jenny</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=720699"><gtr:id>1024A5F7-1D7D-418F-8A1E-3FC0BAB4C636</gtr:id><gtr:title>&amp;quot;Nucleus Pulposus Augmentation&amp;quot; transforming treatment of chronic lower back pain</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>GRD Development of Prototype</gtr:grantCategory><gtr:grantReference>720699</gtr:grantReference><gtr:abstractText>Chronic lower back pain (CLBP) will affect half of the EU population at some time in their lives.
CLBP affects 2.5m UK patients at any time; direct medical costs per patient are &amp;pound;1,074pa.
Time off costs &amp;pound;2,276 p/p pa. Total impact including benefit/insurance is &amp;pound;12bn+. CLBP's most common cause is degeneration in the patient?s intervertebral disc (IVD).
A gap exists in the continuum of care for these patients between conservative (physiotherapy,
painkillers) and aggressive treatments (surgery; fusion, disc replacement). Gelexir Healthcare Limited aim to address this gap with a novel Double Cross-linked Microgel (DXM) that swells upon injection into the patient?s degenerating IVD to augment its mechanical and biological functions, and critically, relieve pain. The gel will be administered via a simple injection in an outpatient setting with minimal anaesthesia. This project will result in a CE marked medical device. Outcomes could see DXM applied to 20% of patients saving the UK (alone) &amp;pound;2.5bn pa.</gtr:abstractText><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>250000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">720699</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>